These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21748257)

  • 1. The use of biomaterials in islet transplantation.
    Borg DJ; Bonifacio E
    Curr Diab Rep; 2011 Oct; 11(5):434-44. PubMed ID: 21748257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet and stem cell encapsulation for clinical transplantation.
    Krishnan R; Alexander M; Robles L; Foster CE; Lakey JR
    Rev Diabet Stud; 2014; 11(1):84-101. PubMed ID: 25148368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of early inflammatory reactions to promote engraftment and function of transplanted pancreatic islets in autoimmune diabetes.
    Piemonti L; Guidotti LG; Battaglia M
    Adv Exp Med Biol; 2010; 654():725-47. PubMed ID: 20217522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of co-aggregates of Sertoli cells and islet cells into liver without immunosuppression.
    Takemoto N; Liu X; Takii K; Teramura Y; Iwata H
    Transplantation; 2014 Feb; 97(3):287-93. PubMed ID: 24342973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.
    Abdulreda MH; Berman DM; Shishido A; Martin C; Hossameldin M; Tschiggfrie A; Hernandez LF; Hernandez A; Ricordi C; Parel JM; Jankowska-Gan E; Burlingham WJ; Arrieta-Quintero EA; Perez VL; Kenyon NS; Berggren PO
    Diabetologia; 2019 May; 62(5):811-821. PubMed ID: 30701283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bio-synthetic materials for immunomodulation of islet transplants.
    Foster GA; García AJ
    Adv Drug Deliv Rev; 2017 May; 114():266-271. PubMed ID: 28532691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet encapsulation: advances and obstacles.
    Weir GC
    Diabetologia; 2013 Jul; 56(7):1458-61. PubMed ID: 23636639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes.
    Tahbaz M; Yoshihara E
    Front Endocrinol (Lausanne); 2021; 12():716625. PubMed ID: 34447354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates.
    Safley SA; Kenyon NS; Berman DM; Barber GF; Willman M; Duncanson S; Iwakoshi N; Holdcraft R; Gazda L; Thompson P; Badell IR; Sambanis A; Ricordi C; Weber CJ
    Xenotransplantation; 2018 Nov; 25(6):e12450. PubMed ID: 30117193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
    Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC
    Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.
    McGuire HM; Walters S; Vogelzang A; Lee CM; Webster KE; Sprent J; Christ D; Grey S; King C
    Diabetes; 2011 Mar; 60(3):867-75. PubMed ID: 21357471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of human islets without immunosuppression.
    Ludwig B; Reichel A; Steffen A; Zimerman B; Schally AV; Block NL; Colton CK; Ludwig S; Kersting S; Bonifacio E; Solimena M; Gendler Z; Rotem A; Barkai U; Bornstein SR
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19054-8. PubMed ID: 24167261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising islet engraftment is critical for successful clinical islet transplantation.
    Korsgren O; Lundgren T; Felldin M; Foss A; Isaksson B; Permert J; Persson NH; Rafael E; Rydén M; Salmela K; Tibell A; Tufveson G; Nilsson B
    Diabetologia; 2008 Feb; 51(2):227-32. PubMed ID: 18040664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.
    Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG
    Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo gene transfer for improvement of transplanted pancreatic islet viability and function.
    Van Linthout S; Madeddu P
    Curr Pharm Des; 2005; 11(22):2927-40. PubMed ID: 16101446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased survival of islet allografts in rats with advanced chronic complications of diabetes.
    Moore WV; Bieser K; Geng Z; Tong PY; Kover K
    Cell Transplant; 2002; 11(7):707-13. PubMed ID: 12518897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte-Derived Dendritic Cells Impair Early Graft Function Following Allogeneic Islet Transplantation.
    Chow KV; Carrington EM; Zhan Y; Lew AM; Sutherland RM
    Cell Transplant; 2017 Feb; 26(2):319-326. PubMed ID: 27743446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of NOD islet isograft from autoimmune destruction by agarose microencapsulation.
    Kobayashi T; Aomatsu Y; Kanehiro H; Hisanaga M; Nakajima Y
    Transplant Proc; 2003 Feb; 35(1):484-5. PubMed ID: 12591496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.